The Impact of Changed Strategies for Patients with Cholangiocarcinoma in This Millenium

Table 1

(a) Clinical staging for patients with intrahepatic cholangiocarcinoma (IHC) in the three time periods. (b) The treatment for 233 patients with intrahepatic cholangiocarcinoma (IHC) in the three time periods.

(a)

Staging/year	2000–2003	2004–2007	2008–2011	Total
T0	1	0	0	1
T1	2	9	12	23
T2	2	0	4	6
T3	13	10	15	38
T4	1	1	3	5
N1	5	14	15	34
M+	17	19	34	70
Not staged	24	27	5	56
Total	65	80	88	233

(b)

Treatment/year	2000–2003	2004–2007	2008–2011	Total
Curative aim
Liver resection	2	6	9	17
Transplantation	1	1	3	5
Active palliative
TACE	0	0	7	7
Chemotherapy	6	14	25	45
Miscellaneous	10	6	1	17
BSC	46	53	43	141
Total	65	80	88	233